- Changing landscape of diagnosis and treatment of bladder cancer
-
Kim WJ
- KMID: 2426511
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S1-S3.
- doi: 10.4111/icu.2016.57.S1.S1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
-
Kim YJ, Kim WJ
- KMID: 2426519
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S77-S88.
- doi: 10.4111/icu.2016.57.S1.S77
Urothelial carcinomas of the urinary bladder have diverse biological and functional characteristics, and numerous factors are likely to be involved in recurrence, progression, and patient survival. While several molecular markers... -
- CITED
-
- Close
- SHARE
-
- Close
- Autophagy and urothelial carcinoma of the bladder: A review
-
Chandrasekar T, Evans CP
- KMID: 2426520
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S89-S97.
- doi: 10.4111/icu.2016.57.S1.S89
The incidence of urothelial carcinoma of the urinary bladder (bladder cancer) remains high. While other solid organ malignancies have seen significant improvement in morbidity and mortality, there has been little... -
- CITED
-
- Close
- SHARE
-
- Close
- Active surveillance for nonmuscle invasive bladder cancer
-
Miyake M, Fujimoto K, Hirao Y
- KMID: 2426512
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S4-S13.
- doi: 10.4111/icu.2016.57.S1.S4
Nonmuscle invasive bladder cancer (NMIBC) is known to be a heterogeneous malignancy that requires varying treatment modalities and follow-up schedules. Low-grade Ta papillary tumors are categorized as low-risk NMIBC because... -
- CITED
-
- Close
- SHARE
-
- Close
- Aberrantly expressed microRNAs in the context of bladder tumorigenesis
-
Lee JY, Ryu DS, Kim WJ, Kim SJ
- KMID: 2426517
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S52-S59.
- doi: 10.4111/icu.2016.57.S1.S52
MicroRNAs (miRNAs), small noncoding RNAs 19-22 nucleotides in length, play a major role in negative regulation of gene expression at the posttranscriptional level. Several miRNAs act as tumor suppressors or... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of microRNAs in bladder cancer
-
Enokida H, Yoshino H, Matsushita R, Nakagawa M
- KMID: 2426518
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S60-S76.
- doi: 10.4111/icu.2016.57.S1.S60
Bladder cancer (BC) is the fifth most common cancer worldwide and is associated with significant morbidity and mortality. The prognosis of muscle invasive BC is poor, and recurrence is common... -
- CITED
-
- Close
- SHARE
-
- Close
- How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
-
Yun SJ, Kim SK, Kim WJ
- KMID: 2426516
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S44-S51.
- doi: 10.4111/icu.2016.57.S1.S44
High-grade T1 bladder cancer has a poor prognosis due to a higher incidence of recurrence and progression than other nonmuscle invasive bladder cancer; thus patients with high-grade T1 have to... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of bladder cancer in the elderly
-
Erlich A, Zlotta AR
- KMID: 2426514
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S26-S35.
- doi: 10.4111/icu.2016.57.S1.S26
As the population ages and life expectancy increases in the human population, more individuals will be diagnosed with bladder cancer (BC). The definition of who is elderly is likely to... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune checkpoint blockade therapy for bladder cancer treatment
-
Kim J
- KMID: 2426521
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S98-S105.
- doi: 10.4111/icu.2016.57.S1.S98
Bladder cancer remains the most immunogenic and expensive malignant tumor in the United States today. As the 4th leading cause of death from cancer in United States, Immunotherapy blocking immune... -
- CITED
-
- Close
- SHARE
-
- Close
- Dietary factors associated with bladder cancer
-
Piyathilake C
- KMID: 2426513
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S14-S25.
- doi: 10.4111/icu.2016.57.S1.S14
It is biologically plausible for dietary factors to influence bladder cancer risk considering that beneficial as well as harmful components of a diet are excreted through the urinary tract and... -
- CITED
-
- Close
- SHARE
-
- Close
- Open versus robotic cystectomy: Comparison of outcomes
-
Davis RB, Farber NJ, Tabakin AL, Kim IY, Elsamra SE
- KMID: 2426515
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S36-S43.
- doi: 10.4111/icu.2016.57.S1.S36
Open radical cystectomy (ORC) is the current gold standard treatment for muscle invasive bladder cancer. As surgeons become more proficient in minimally invasive and robotic surgical techniques, the number of... -
- CITED
-
- Close
- SHARE
-
- Close
